Dr Jeffrey Goh is an experienced, compassionate medical oncologist with a strong commitment to achieving the best possible outcomes for his patients. He combines an active interest in research and clinical trials with an empathetic approach to care, to support the physical and emotional needs of his patients throughout their cancer journey.
Dr Jeffrey Goh is an experienced medical oncologist consulting at Icon Cancer Centre Chermside. In 1996, he completed his Bachelor of Medicine, Bachelor of Surgery at Monash University and moved from Adelaide to Brisbane to establish his medical career at Greenslopes Private Hospital as a haematology and oncology registrar in 2002. Dr Goh subsequently held a position as a laboratory and clinical haematology registrar at the Princess Alexandra Hospital in 2003. He completed his three years of advanced specialist medical oncology training in Brisbane and became a Fellow of the Royal Australasian College of Physicians (FRACP) in 2007.
Dr Goh represented the Queensland Medical Oncology Advanced Trainees within the Medical Oncology Group of Australia (MOGA) in 2007 prior to his appointment as staff medical oncologist at Royal Brisbane & Women’s Hospital (RBWH) in December 2008. Dr Goh commenced sessional private medical oncology practice as a Visiting Medical Officer (VMO) at Greenslopes Private Hospital (GPH) in 2008 and at Icon Cancer Centre Chermside in early 2010.
Dr Goh is actively involved in numerous clinical trials and acted as principal investigator (PI) in a number of phase I/Ib, II and III gynaecological oncology, urological malignancy and early phase drug trials at RBWH, Icon and GPH. He is also a co-investigator in numerous other multi-centre clinical trials in oncology.
Dr Goh maintains an active interest in clinical research and is a member of several leading cancer trial groups including the Australian and New Zealand Urogenital & Prostate Cancer Trials Group (ANZUP), American Society of Clinical Oncology (ASCO), Australasian Lung Cancer Trialist Group (ALTG) and European Society of Medical Oncology (ESMO). He was previously a Board Member and chair of the QA Committee of the Australia & New Zealand Gynaecological Oncology Group (ANZGOG) and is the current Chair of the Cervical Cancer Tumour Type Working Group of ANZGOG.
Dr Goh maintains a significant part-time role as Senior Staff Specialist at RBWH and is a senior lecturer; he is co-supervisor of PhD candidates at the University of Queensland. He is also involved with mentoring advanced trainee registrars in Medical Oncology at RBWH. Additionally, Dr Goh is a member of both the Research Committee and Medical Advisory Committee (MAC) at Icon.
Dr Goh’s clinical experience covers a broad range of solid tumour malignancies, with special clinical interest in gynaecological, genitourinary and colorectal cancers, in addition to phase I/Ib clinical trials.